AFC-HD AMS Life Science Co.,Ltd. [2927.T]
TOKYO, Jun 02 (Pulse News Wire) – Afc-hd AMS Life Science CO.,LTD. (2927.T) disclosed plans aimed at enhancing asset value and capital efficiency through the activation of its real estate holdings.
As of May 28, the company's market valuation was below its book equity, reflecting a disconnect between perceived intrinsic value and share price. The company’s portfolio includes premium properties such as those in Yokosuka and Fujisawa, valued collectively at approximately 8 billion based on recent appraisals. Incorporating potential gains from these assets, the estimated per-share intrinsic net worth stands at around ¥415, significantly higher than the current stock price of ¥21.00 billion as of June 1, 2026.
To bridge this gap, AFC-HD AMS Life Science is pursuing strategies to monetize its real estate assets more effectively. Initiatives include converting traditional retail space into experiential commercial ventures, exemplified by the successful launch of Round One on May 28, 2026. Additionally, the company is participating in redevelopment projects like the Ootaki-machi 1-chome area in Yokosuka, aiming to transform existing assets into high-value mixed-use complexes.
Looking ahead, the firm intends to optimize asset management and explore various growth investments and shareholder returns to align its market valuation with its true intrinsic value.
🟡 Confidence: Standard AI-translated content.